£515.00

It has never been this cheap. We have no record of a lower price.

£515 today · cheaper than every other day in the last 3 months

The 2023-2028 Outlook for Botulinum Toxins in India

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 37 days · 37 data points (no recent data)

Historical
Generating forecast…
£515.00 £489.25 £499.55 £509.85 £520.15 £530.45 £540.75 22 August 2026 31 August 2026 09 September 2026 18 September 2026 27 September 2026
View at Amazon ↗

Price data last checked 54 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 37 days • 1 price levels

Days at Price
37 days 0 9 19 28 37 £515 Days at Price

Price Analysis

Most common price: £515 (37 days, 100.0%)

Price range: £515 - £515

Price levels: 1 different prices over 37 days

Description

This study covers the latent demand outlook for botulinum toxins across the states, union territories, and cities of India. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across over 4,900 cities in India. For each city in question, the percent share the city is of its state or union territory and of India as a whole is reported. These comparative benchmarks allow the reader to quickly gauge a city vis-à-vis others. This statistical approach can prove very useful to distribution and/or sales force strategies. Using econometric models which project fundamental economic dynamics within each state, union territory, and city, latent demand estimates are created for botulinum toxins. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of botulinum toxins as including all commonly understood products falling within this broad category, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include Allergan, Daewoong Pharmaceutical Company, Galderma, HUGEL Pharma, Hugh Source (International), Ltd., Inc., Ipsen, Lanzhou Institute of Biological Products Company, Medytox, Medy-Tox, Mentor, Merz Pharma, Metabiologics, Revance Therapeutics, U.S. WorldMeds, and US Worldmed, LLC. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2022).

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
14 September 2022
Listed Since
28 September 2022

Similar Products You Might Like

The 2023-2028 Outlook for Aesthetic Medicines in India
91% match

The 2023-2028 Outlook for Aesthetic Medicines in India

£515.00 27 Sep 2026
The 2023-2028 Outlook for Aesthetics Combination Therapies in India
90% match

The 2023-2028 Outlook for Aesthetics Combination Therapies in India

£515.00 27 Sep 2026
The 2023-2028 Outlook for Aesthetic Medicines in the United States
89% match

The 2023-2028 Outlook for Aesthetic Medicines in the United States

£520.00 27 Sep 2026
The 2023-2028 Outlook for Skincare Devices in India
89% match

The 2023-2028 Outlook for Skincare Devices in India

£515.00 27 Sep 2026
The 2023-2028 Outlook for Therapeutics for Optometry in India
89% match

The 2023-2028 Outlook for Therapeutics for Optometry in India

£515.00 27 Sep 2026
The 2023-2028 Outlook for Proliferative Diabetic Retinopathy Treatments in India
88% match

The 2023-2028 Outlook for Proliferative Diabetic Retinopathy Treatments in India

£515.00 27 Sep 2026
The 2023-2028 Outlook for Pruritus Corticosteroid Therapeutics in India
88% match

The 2023-2028 Outlook for Pruritus Corticosteroid Therapeutics in India

£515.00 27 Sep 2026
The 2023-2028 Outlook for Myasthenia Gravis Treatments in India
88% match

The 2023-2028 Outlook for Myasthenia Gravis Treatments in India

£515.00 27 Sep 2026
The 2023-2028 Outlook for Dermocosmetics Beauty and Personal Care in India
88% match

The 2023-2028 Outlook for Dermocosmetics Beauty and Personal Care in India

£515.00 16 Nov 2026
The 2023-2028 Outlook for Diabetic Retinopathy Treatments in India
88% match

The 2023-2028 Outlook for Diabetic Retinopathy Treatments in India

£515.00 27 Sep 2026
The 2023-2028 Outlook for Artificial Tears in India
88% match

The 2023-2028 Outlook for Artificial Tears in India

£515.00 27 Sep 2026
The 2023-2028 Outlook for Biologic Vasculitis Treatments in India
88% match

The 2023-2028 Outlook for Biologic Vasculitis Treatments in India

£515.00 27 Sep 2026
The 2023-2028 Outlook for GLP-1 Agonists for Type 2 Diabetes in India
88% match

The 2023-2028 Outlook for GLP-1 Agonists for Type 2 Diabetes in India

£515.00 27 Sep 2026
The 2023-2028 Outlook for Anti-Aging Cosmetic Skin Care in India
88% match

The 2023-2028 Outlook for Anti-Aging Cosmetic Skin Care in India

£515.00 27 Sep 2026
The 2023-2028 Outlook for Diabetic Gastroparesis Treatments in India
88% match

The 2023-2028 Outlook for Diabetic Gastroparesis Treatments in India

£515.00 27 Sep 2026
The 2023-2028 Outlook for Skin Tears Treatments in India
88% match

The 2023-2028 Outlook for Skin Tears Treatments in India

£515.00 27 Sep 2026
The 2023-2028 Outlook for Hyperhidrosis Treatments in the United States
88% match

The 2023-2028 Outlook for Hyperhidrosis Treatments in the United States

£520.00 27 Sep 2026
The 2023-2028 Outlook for Myasthenia Gravis Drugs in India
88% match

The 2023-2028 Outlook for Myasthenia Gravis Drugs in India

£515.00 27 Sep 2026
The 2023-2028 Outlook for Pediatric Health Care Products in India
88% match

The 2023-2028 Outlook for Pediatric Health Care Products in India

£515.00 27 Sep 2026
The 2023-2028 Outlook for Facial Water Sprays in India
88% match

The 2023-2028 Outlook for Facial Water Sprays in India

£515.00 27 Sep 2026
The 2023-2028 Outlook for Cutaneous Melanoma Therapeutics in India
88% match

The 2023-2028 Outlook for Cutaneous Melanoma Therapeutics in India

£515.00 27 Sep 2026
The 2023-2028 Outlook for Orphan Biologic Drugs in India
88% match

The 2023-2028 Outlook for Orphan Biologic Drugs in India

£515.00 27 Sep 2026
The 2023-2028 Outlook for Medicated Skin Care in India
88% match

The 2023-2028 Outlook for Medicated Skin Care in India

£515.00 27 Sep 2026
The 2023-2028 Outlook for Amino Acid Metabolism Disorders Treatments in India
88% match

The 2023-2028 Outlook for Amino Acid Metabolism Disorders Treatments in India

£515.00 27 Sep 2026